Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06NNQ
|
|||
| Former ID |
DNCL003029
|
|||
| Drug Name |
VRC-HIVADV014-00-VP
|
|||
| Indication | Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 279.3] | Phase 2 | [1] | |
| Company |
GenVec; Vaccine Research Center (NIAID)
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00498056) Safety and Effectiveness of an HIV DNA Vaccine Followed by an HIV Adenoviral Vector Vaccine for Prevention of HIV Infection in the Americas and Africa. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.